Ethema Health Corporation 's ability to collect accounts receivable sequentially worsen to 11.72, indicating more challenging environment then in the second quarter 2025, but still, it is a far cry from any concerns. Ethema Health 's Accounts Receivable average collection period in the Sep 30 2025 quarter, has increased to 31 days, from 25 days, in the Jun 30 2025 quarter.

If we take a look into Healthcare sector 89 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2025 from 749 to 977.

What is Receivable Turnover Ratio?
What is Ethema Health Corporation Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GRST Receivables Turnover Ratio	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter
Y / Y Receivable Change	538.75 %	11157.89 %	190.71 %	-16.75 %	-44.01 %
Y / Y Revenue Change	214.17 %	229.2 %	170.58 %	30.39 %	29.99 %
Receivable Turnover Ratio (TTM)	11.72	14.53	19.45	23.77	21.31
GRST's Total Ranking	# 977	# 749	# 612	# 571	# 2045
Accounts Receivable average collection period days	31	25	19	15	17
Seq. Receivable Change	59.42 %	47.24 %	297.81 %	-31.59 %	2709.72 %
Seq. Revenue Change	12.72 %	39.45 %	139.79 %	-16.65 %	18.11 %

Receivable Turnover Company Ranking
Within:	No.
Healthcare Facilities Industry	# 8
Healthcare Sector	# 90
Overall Market	# 977

Receivable Turnover Ratio Statistics
High	Average	Low
25.75	9.84	-7.81
(Dec 31 2015)		(Dec 31 2017)

GRST Company Profile • Back to GRST Efficiency Comparisons • Compare GRST Receivables Turnover Ratio to its Competitors

Financial Statements
Ethema Health 's Accounts Receivable	$ 2 Millions	Visit GRST's Balance sheet
Ethema Health 's Sales TTM	$ 15 Millions	Visit GRST's Income Statement
Sources of GRST's Revenues		Visit GRST's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GRST's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
GRST's Growth Rates	GRST's Roa	GRST's Inventory Turnover Ratio	GRST's Dividend Comparisons
GRST's Profitability Ratios	GRST's Roi	GRST's Asset Turnover Ratio	GRST's Dividend Growth
GRST's Valuation Ratios	GRST's Roe	GRST's Financial Strength Ratios	GRST's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2025	Receivable at quarter ending Sep 30 2025
Marpai Inc	17.32	$ 20.702 Millions	$ 1.195 Millions
Lucid Diagnostics Inc	17.10	$ 4.399 Millions	$ 0.257 Millions
Valion Bio Inc	16.91	$ 0.482 Millions	$ 0.029 Millions
Meiragtx Holdings Plc	16.70	$ 27.417 Millions	$ 1.642 Millions
Talkspace Inc	16.12	$ 214.505 Millions	$ 13.310 Millions
Voyager Therapeutics Inc	15.68	$ 31.316 Millions	$ 1.997 Millions
Amneal Pharmaceuticals Inc	15.06	$ 2,933.636 Millions	$ 194.776 Millions
Xoma Royalty Corporation	14.75	$ 47.106 Millions	$ 3.193 Millions
Mannkind Corporation	14.73	$ 313.787 Millions	$ 21.307 Millions
Qhslab Inc	14.68	$ 2.751 Millions	$ 0.187 Millions
Milestone Scientific Inc	14.65	$ 8.734 Millions	$ 0.596 Millions
Kiniksa Pharmaceuticals International Plc	14.46	$ 597.973 Millions	$ 41.360 Millions
Vivos Therapeutics Inc	13.55	$ 16.653 Millions	$ 1.229 Millions
Clene Inc	13.38	$ 0.214 Millions	$ 0.016 Millions
Inmed Pharmaceuticals Inc	13.34	$ 4.798 Millions	$ 0.360 Millions
Ensysce Biosciences Inc	13.24	$ 4.488 Millions	$ 0.339 Millions
China Pharma Holdings Inc	13.14	$ 4.052 Millions	$ 0.308 Millions
Icu Medical Inc	12.80	$ 2,319.576 Millions	$ 181.198 Millions
Rosecliff Acquisition Corp I	12.64	$ 24.634 Millions	$ 1.949 Millions
Sutro Biopharma Inc	12.39	$ 105.646 Millions	$ 8.525 Millions
Newamsterdam Pharma Company N v	12.34	$ 35.243 Millions	$ 2.856 Millions
Scorpius Holdings inc	12.30	$ 1.716 Millions	$ 0.140 Millions
Harvard Apparatus Regenerative Technology Inc	12.23	$ 0.743 Millions	$ 0.061 Millions
Cytokinetics Incorporated	12.08	$ 87.211 Millions	$ 7.220 Millions
Option Care Health Inc	12.01	$ 5,532.505 Millions	$ 460.534 Millions
Corcept Therapeutics Inc	11.86	$ 741.172 Millions	$ 62.498 Millions
Ss Innovations International Inc	11.86	$ 40.946 Millions	$ 3.454 Millions
Chemed Corporation	11.80	$ 2,530.634 Millions	$ 214.372 Millions
Ethema Health Corporation	11.72	$ 15.420 Millions	$ 1.315 Millions
Skinhealth Systems Inc	11.55	$ 301.672 Millions	$ 26.128 Millions

Date modified: 2026-03-03T10:47:30+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.